BTG1B-Cell Translocation Gene 1
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Wu, "Insulin-like growth factor I differentially regulates the expression of HIRF1/hCAF1 and BTG1 genes in human MCF-7 breast cancer cells," International Journal of Molecular Medicine, vol.
[5] Human genes: CD2, CD2 molecule; CD3E, CD3e molecule, e (CD3-TCR complex); LCK, lymphocyte-specific protein tyrosine kinase; GZMA, granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3); CD28, CD28 molecule; MNDA, myeloid cell nuclear differentiation antigen; LYN, v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; MYC, v-myc myelocytomatosis viral oncogene homolog (avian); BTG1, B-cell translocation gene 1, anti-proliferafive; CD79A, CD79a molecule, immunoglobulin-associated a; FAIM3, Fas apoptotic inhibitory molecule 3; CCR7, chemokine (C-C mofif) receptor 7; CD48, CD48 molecule; HLA-DRA, major histocompatibility complex, class II, DR a; FCER2, Fc fragment of IgE, low affinity II, receptor for (CD23); CD52, CD52 molecule.
zon ches Color ture ture tence Redox In/hr Ap 0-9 very silty weak friable 0.6-2 dark clay fine and gray loam medium (10YR3/ granular 1) A 9-16 black silty moderate firm 0.6-2 (10YR2/ clay fine and 1) loam medium angular blocky Btg1 16-31 dark silty moderate firm common 0.2-0.6 gray clay medium medium (5YR4/ loam and fine dis- 1) sub- tinct angular dark and yello- angular wish blocky brown (10YR4/ 4) and few medium promi- nent yello- wish brown (10YR5/ 6) iron oxide masses Btg2 31-50 olive silty moderate firm common 0.2-0.6 gray clay coarse coarse (5YR5/ loam sub- promi- 2) angular nent blocky strong brown (7.5YR 5/6) and yello- wish brown (10YR5/ 8) iron oxide masses 2C 50-64 brown loam massive friable 0.2-0.6 (10YR5/ 3) [ILLUSTRATION OMITTED]
miRNAs downregulated in chemoresistance to conventional drugs miR-22 5-FU BTG1 miR-34a 5-FU SIRT1, E2F3, KIT, LDHA miR-122 5-FU PKM2 miR-129 5-FU BCL2, TYMS, E2F3 miR-133a Oxaliplatin RFFL miR-139-5p 5-FU NOTCH1 miR-141/200c Oxaliplatin ZEB1 miR-143 5-FU, oxaliplatin BCL2, NFKB, ERK5, IGF1R miR-145 5-FU FLI-1, RAD18 miR-149 5-FU FOXM1 miR-153 Oxaliplatin FOXO3 miR-196a Oxaliplatin HOXA7, HOXB8, HOXC8, HOXD8 miR-200 cluster 5-FU EMT-related genes miR-203 5-FU TYMS miR-204 5-FU HMGA2 miR-222 Oxaliplatin ADAM17 miR-297 Oxaliplatin ABCC2 miR-451 Irinotecan ABCC1 miR-497 5-FU, irinotecan IGF1R miR-519c 5-FU, oxaliplatin ABCG2, ELAVL1 (HuR) miR-1915 Oxaliplatin BCL2 miRNAs overexpressed in chemoresistance to monoclonal antibody-based therapies miR-17-3p Cetuximab ?
The mutation c.2975C>T abolished the only Btg1 site in the PCR products.